Genomic Assessment of Patients With Severe Radiation Reactions

Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal

NCT05530759 ·Status: RECRUITING

Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy

NCT05112627 ·Status: COMPLETED

Optical Genome Mapping in Characterization of Multiple Myeloma

NCT05786105 ·Status: COMPLETED

Evaluating a Pharmacogenetic Testing Panel in Patients Suspected to be at Increased Risk for Pharmacogenetics-related AEs While Receiving Fluoropyrimidine or Irinotecan Therapy

NCT05583422 ·Status: COMPLETED

Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population

NCT05837884 ·Status: RECRUITING

Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing

NCT06550427 ·Status: RECRUITING

Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer

NCT00899808 ·Status: WITHDRAWN

ctDNA in Patients With Thyroid Nodules

NCT02778412 ·Status: TERMINATED

S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma

NCT00985699 ·Status: COMPLETED

Selecting a Favorable KIR Donor in Unrelated HCT for AML

NCT01288222 ·Status: COMPLETED ·Phase: NA

Comparison of Immune Response Following Surgical Management of Renal Tumors

NCT00289146 ·Status: TERMINATED

Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.

NCT05083494 ·Status: UNKNOWN

Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma

NCT05693012 ·Status: UNKNOWN

Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease

NCT02612350 ·Status: COMPLETED

Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool

NCT02791217 ·Status: UNKNOWN

Treatment Resistance Related With Gene Expression Profile of Diffuse Large B-cell Lymphoma

NCT01606605 ·Status: COMPLETED

Liquid Biopsy in Mature B-cell Tumors

NCT03280394 ·Status: RECRUITING

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

NCT02269592 ·Status: RECRUITING

Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer

NCT05758948 ·Status: UNKNOWN

Micro Assays for HemATology Malignancies Antibody Treatment

NCT07018310 ·Status: NOT_YET_RECRUITING ·Phase: NA

Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM.

NCT01079429 ·Status: TERMINATED

MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies

NCT06543511 ·Status: WITHDRAWN ·Phase: NA

Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer

NCT06979895 ·Status: NOT_YET_RECRUITING

Malignant Hyperthermia Registry and Genetic Testing

NCT02964481 ·Status: TERMINATED

A Study of the Role of Circulating Tumor DNA in Predicting the Likelihood of Organ Preservation After Clinical Complete Response to Neoadjuvant Therapy for Rectal Cancer

NCT03749083 ·Status: WITHDRAWN